Envisagenics

Long Island City, NY · Founded 2014 · Privately Held (backing)

Developer of a bioinformatics platform designed to accelerate the development of novel therapeutics. Envisagenics is based in Long Island City, NY and was founded in 2014. Its last known valuation is $150 million. It has raised $40.5 million across 2 recorded rounds; the latest was a $19.2 million early-stage round in Sep 2021.

Last price · $/share
—
Implied valuation
$150.0M
Total raised
$40.5M
Last round
Early Stage VC
Sep 2021
How much has Envisagenics raised?
$40.5Macross 2 recorded rounds · Mar 2017 – Sep 2021

Most recently, Envisagenics raised $19.2M in its Early Stage VC (Sep 2021).

Free account
More of Envisagenics with a free account
  • ·The complete investor list: 24 names
  • ·Watch Envisagenics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Envisagenics round by round

2 rounds
Sep 2021Early Stage VC$19.2MSEC filing▮
24 investors participated
Mar 2017Seed Round$2.5MSEC filing▮
6 investors participated

How much has Envisagenics raised?

Envisagenics has raised $40.5 million in total; 2 of its rounds are on record. The largest on record was a $2.5 million seed round in Mar 2017; the most recent was a $19.2 million early-stage round in Sep 2021.

Envisagenics has filed 3 Form Ds with the SEC since 2017, most recently in Oct 2021 ($19.2 million sold to 24 investors).

Envisagenics investors

24 investors are on record for Envisagenics, including SV Angel, National Institutes of Health, M12 and Madrona Venture Group. By type, the record holds 6 venture capital firms and 1 family office. The early-stage round in Sep 2021 drew 24 investors.

For fundraisers
Raising for a company like Envisagenics?

24 investors have backed Envisagenics.

See all 24 investors →

Frequently asked about Envisagenics

How much has Envisagenics raised?
Envisagenics has raised $40.5M in total across 2 recorded funding rounds.
When was Envisagenics's last funding round?
Envisagenics's most recent recorded round was Early Stage VC in Sep 2021, raising $19.2M.